Assessment of Alzheimer's disease case-control associations using family-based methods

Neurogenetics

Volumn 10, Issue 1, 2009, Pages 19-25

  Schjeide, Brit Maren M ^a   McQueen, Matthew B ^b,c   Mullin, Kristina ^a   Divito, Jason ^a   Hogan, Meghan F ^a   Parkinson, Michele ^a   Hooli, Basavaraj ^a   Lange, Christoph ^b   Blacker, Deborah ^a,b   Tanzi, Rudolph E ^a   Bertram, Lars ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Alzheimer's disease; Family based association testing; Genetic association; Meta analysis; Risk factors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CELL SURFACE RECEPTOR; CYSTATIN C; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1BETA; LAMIN A; MITOCHONDRIAL PROTEIN; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 13; NERVE PROTEIN; NICOTINIC RECEPTOR BETA2; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PRESENILIN 1; PRION PROTEIN; PROTEIN PCK1; PROTEIN SORCS1; PROTEIN SORL1; PROTEIN TFAM; PROTEIN TNK1; PROTEIN TYROSINE KINASE; TAU PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 7P; DNA POLYMORPHISM; ETHNICITY; GALP GENE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GWA 14Q32.13 GENE; GWA 7P15.2 GENE; HAPLOTYPE; HCG2039140 GENE; HUMAN; LOC439999 GENE; LOC651924 GENE; PGBD1 GENE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DATABASES, GENETIC; ETHNIC GROUPS; FAMILY; GENETIC SCREENING; GENOTYPE; HUMANS;

EID: 58649121718     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-008-0151-3     Document Type: Article

References (31)

1. L Bertram MB McQueen K Mullin D Blacker RE Tanzi 2007 Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nat Genet 39 17 23
2. L Bertram D Blacker A Crystal K Mullin D Keeney J Jones 2000 Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies Exp Gerontol 35 1353 1361
3. E Rogaeva Y Meng JH Lee Y Gu T Kawarai F Zou 2007 The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease Nat Genet 39 168 177
4. NM Laird C Lange 2006 Family-based designs in the age of large-scale gene-association studies Nat Rev Genet 7 385 394
5. D Blacker JL Haines L Rodes H Terwedow RC Go LE Harrell 1997 ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative Neurology 48 139 147
6. L Bertram M Hiltunen M Parkinson M Ingelsson C Lange K Ramasamy 2005 Family-based association between Alzheimer's disease and variants in UBQLN1 N Engl J Med 352 884 894
7. FA Sayed-Tabatabaei BA Oostra A Isaacs CM van Duijn JC Witteman 2006 ACE polymorphisms Circ Res 98 1123 1133
8. D Rabinowitz N Laird 2000 A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information Hum Hered 50 211 223
9. Fisher RA (1932) Statistical methods for research workers. Oliver and Boyd, Edinburgh
10. JS Witte WJ Gauderman DC Thomas 1999 Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs Am J Epidemiol 149 693 705
11. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188
12. C Lange D DeMeo EK Silverman ST Weiss NM Laird 2004 PBAT: tools for family-based association studies Am J Hum Genet 74 367 369
13. A Grupe R Abraham Y Li C Rowland P Hollingworth A Morgan 2007 Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants Hum Mol Genet 16 865 873
14. Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, Goate AM (2009) Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta. Neurogenetics. doi: 10.1007/s10048-008-0150-4
15. S Takeda N Sato T Ogihara R Morishita 2008 The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential Front Biosci 13 2253 2265
16. B Keavney CA McKenzie JM Connell C Julier PJ Ratcliffe E Sobel 1998 Measured haplotype analysis of the angiotensin-I converting enzyme gene Hum Mol Genet 7 1745 1751
17. PG Kehoe H Katzov L Feuk AM Bennet B Johansson B Wiman 2003 Haplotypes extending across ACE are associated with Alzheimer's disease Hum Mol Genet 12 859 867
18. JS Miners E Ashby Z Van Helmond KA Chalmers LE Palmer S Love 2008 Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy Neuropathol Appl Neurobiol 34 181 193
19. J Hu A Igarashi M Kamata H Nakagawa 2001 Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity J Biol Chem 276 47863 47868
20. EA Eckman SK Adams FJ Troendle BA Stodola MA Kahn AH Fauq 2006 Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme J Biol Chem 281 30471 30478
21. ML Hemming DJ Selkoe W Farris 2007 Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease Neurobiol Dis 26 273 281
22. GJ Brewer 2007 Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease Exp Biol Med (Maywood) 232 323 335
23. DA Loeffler JR Connor PL Juneau BS Snyder L Kanaley AJ DeMaggio 1995 Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions J Neurochem 65 710 724
24. MA Smith PL Harris LM Sayre G Perry 1997 Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc Natl Acad Sci U S A 94 9866 9868
25. A Yamamoto RW Shin K Hasegawa H Naiki H Sato F Yoshimasu 2002 Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease J Neurochem 82 1137 1147
26. PL Lee NJ Ho R Olson E Beutler 1999 The effect of transferrin polymorphisms on iron metabolism Blood Cells Mol Dis 25 374 379
27. P Zatta L Messori P Mauri SJ van Rensburg J van Zyl S Gabrielli 2005 The C2 variant of human serum transferrin retains the iron binding properties of the native protein Biochim Biophys Acta 1741 264 270
28. D Kalamida K Poulas V Avramopoulou E Fostieri G Lagoumintzis K Lazaridis 2007 Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity FEBS J 274 3799 3845
29. S Oddo FM LaFerla 2006 The role of nicotinic acetylcholine receptors in Alzheimer's disease J Physiol (Paris) 99 172 179
30. H Tohgi K Utsugisawa M Yoshimura Y Nagane M Mihara 1998 Age-related changes in nicotinic acetylcholine receptor subunits alpha4 and beta2 messenger RNA expression in postmortem human frontal cortex and hippocampus Neurosci Lett 245 139 142
31. LA Farrer LA Cupples JL Haines B Hyman WA Kukull R Mayeux 1997 Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium JAMA 278 1349 1356